Lotus Pharmaceuticals (LTUS) Short Interest Ratio & Short Volume

Short interest is the volume of Lotus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 600 shares of LTUS short. Learn More on Lotus Pharmaceuticals' current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lotus Pharmaceuticals: Akari Therapeutics, Plc (1.05%), Daré Bioscience, Inc. (1.02%), Bullfrog AI Holdings, Inc. (7.61%), Onconetix, Inc. (42.36%), Allakos Inc. (2.73%), Natural Alternatives International, Inc. (0.08%), Chemomab Therapeutics Ltd. (0.45%), DURECT Co. (2.92%), Cognition Therapeutics, Inc. (1.56%), LAVA Therapeutics (0.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

Short selling LTUS is an investing strategy that aims to generate trading profit from Lotus Pharmaceuticals as its price is falling. LTUS shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lotus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LTUS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LTUS, twice per month. The most recent reporting period available is January, 15 2025.